特发性膜性肾病的治疗进展
摘要
目前对于特发性膜性肾病 (IMN)虽无公认的治疗方法 ,但近年来在免疫抑制疗法和非免疫抑制疗法上均有较大的进展 ,也出现了众多的生化制剂 。
出处
《国外医学（泌尿系统分册）》
2004年第1期131-133,共3页
Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
参考文献20
-
1Ponticelli C,Passerini P.Membranous glomerulonephritis.In:Massry SG,Glassock RJ,eds.Massry & Glassock's Textbook of Nephrology.4th ed.Philadelphia:Lippineott Williams & Wilkins,2001,707～713
-
2吴义超,刘志红,苏健,周虹,曾彩虹,黎磊石.特发性膜性肾病的分子病理特征[J].肾脏病与透析肾移植杂志,2003,12(2):153-155. 被引量：16
-
3刘刚,王海燕.特发性膜性肾病的特异性治疗[J].中华肾脏病杂志,2002,18(6):450-451. 被引量：31
-
4Cattran DC.Idiopathic membranous glomerulonephritis.Kidney Int,2001,59,1983～1994
-
5Fritsche L,Budde K,Farber L,et al.Treatment of membranous glomerulopathy with cyclosporine A:How much patience is required?Nephrol Dial Transplant,1999,14,1036～1037
-
6AlvaroTorres,BeatrizPominguez-Gil,AugustinCarreno,et al.Conservative versus immunosuppressive treatment of patients with idiopathic membranousnephropathy.Kidney Int,2002,61,217
-
7Michael J,Choi,Joseph A,et al.Mycophenolate mofetil treatment for primary glomerular diseases.Kidney Int,2002,61,1098～1114
-
8Miller G,Zimmerman R,Radhakrishnan J,et al.Use of mycophenolate mofetil in resistant membranous nephropathy.Am J Kidney Dis,2000,36,250～256
-
9Alexopoulos E,Papagianni A.Treatment of idiopathic membranous nephropathy.Renal Failure,2002,22(6),697～709
-
10Roberto Pisoni,Piero Ruggenenti,Fabio Sangalli,et al.Effect of high dose ramipril with or without indomethacin on glomerular selectivity.Kidney Int,2002,62(3),1523～1755
二级参考文献21
-
1Kerjaschki D. Pathogenetic concepts of membranous glomerulopathy(MGN). J Nephrol, 2000,13(s3):S96.
-
2Hirayama K, Ebihara I, Yamamoto S et al. Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis.Nephron,2002,91(2):255.
-
3Ollveira DB. Membranous nephropathy: an IgG4-mediated disease. Lancet,1998,351:670.
-
4Bijl M, Dijstelbloem HM, Oost WW et al. IgG subclass distribution of autoantibodies differs between renal and extra-renal relspses in patients with systemic lupus erythematosus. Rheunmatology (Oxford), 2002, 41(1): 62.
-
5Holdsworth SR, Kitching R, Tipping PG et al. Th1 and Th2 helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int, 1999, 55:1198.
-
6Folk R J, Jennette JC, Nachman PH.Membranous glomerulopathy. In: Brenner BM, ed. Brenner & Rector's The Kidney.6th ed. Philadelphia: W B Saunders,1999. 1284-1292.
-
7Ponticelli C, Passerini P. Membranous glomerulonephritis. In: Massry SG, Glassock RJ, eds. Massry & Glassock's Textbook of Nephrology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001. 707-713.
-
8Muirhead N. Management of idiopathic membranous nephropathy: evidence-based recommendations. Kidney Int, 1999, S70:S47-S55.
-
9Kida H, Asamoto T, Yokoyama H, et al.Long-term prognosis of idiopathic membranous nephropathy. Clin Nephrol, 1986,25: 64-69.
-
10Ponticelli C, Zucchelli P, Passerini P, et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int, 1995, 48: 1600-1604.
共引文献53
-
1孟曦,丁伟,王耀光(指导).王耀光教授治疗特发性膜性肾病的临床经验[J].内蒙古中医药,2023,42(4):81-83. 被引量：1
-
2相敏,鲁凌飞,李雨彦,卢建东,熊国良.雷公藤治疗成人特发性膜性肾病的疗效及减少蛋白尿的Meta分析[J].内蒙古中医药,2022,41(10):163-168.
-
3向群,姚强,丁晔,阮力.辛伐他汀与贝那普利单用或联用治疗糖尿病肾病[J].中国新药与临床杂志,2005,24(6):440-443. 被引量：7
-
4郑丹侠,宋燕,史均宝,韩庆烽,张爱华.原发性膜性肾病85例治疗回顾性纷析[J].临床荟萃,2005,20(20):1145-1147. 被引量：2
-
5应丽红.糖尿病肾功能衰竭28例临床治疗分析[J].浙江临床医学,2005,7(9):929-929.
-
6邵淑芹,肖青.免疫抑制剂在治疗肾小球疾病中的应用进展[J].潍坊医学院学报,2006,28(1):54-57. 被引量：3
-
7王金泉.有机溶剂相关性肾小球膜性病变及肾小管间质损害[J].肾脏病与透析肾移植杂志,2006,15(1):95-100. 被引量：3
-
8韩从华,秦前安,别艳芝.疏血通注射液联合前列腺素E_1对原发性膜性肾病的治疗作用[J].深圳中西医结合杂志,2006,16(5):286-288.
-
9包自阳,朱彩凤,陈洪宇.雷公藤治疗肾小球肾炎的研究近况[J].浙江中医杂志,2007,42(1):51-53. 被引量：8
-
10张凌,胡章学,付平,沙朝晖.特发性膜性肾病的免疫抑制治疗[J].中国中西医结合肾病杂志,2007,8(2):116-119.
-
1陈薇,王德光.特发性膜性肾病的治疗进展[J].国外医学（老年医学分册）,2009,30(4):185-189. 被引量：5
-
2洪享.主动脉瓣介入治疗取得很大突破[J].心血管病防治知识,2012(7):20-21.
-
3刘华锋.溶血性尿毒症综合征的研究进展[J].国外医学（泌尿系统分册）,2002,22(4):224-226. 被引量：2
-
4李丹,卡索.应用带锁髓内针治疗33例下肢长骨干骨折[J].华北国防医药,2003,15(5):355-356.
-
5张洪义.异种移植[J].中国现代普通外科进展,1999,2(1):21-22. 被引量：1
-
6包玉生.异种移植[J].日本医学介绍,1995,16(9):419-421.
-
7杨露绮.肝移植的药物治疗[J].传染病网络动态,2003(1):29-30.
-
8王和平,杨建文.骨康泰灵治疗骨折临床观察[J].甘肃科技,2000,16(5):51-51.
-
9柴坦,王凤茹.心脏移植受体的免疫抑制疗法[J].心血管病学进展,1991,12(4):232-233.
-
10郭克建.活体部分肝移植[J].日本医学介绍,1994,15(10):436-438.
